Poultry Anticoccodial Drugs Market Size & Share Analysis - Growth, Trends And Forecast (2025 - 2030)

The Poultry Anticoccodial Drugs Market Report is Segmented by Drug Class (Ionophore, Antibiotic, Sulphonamides, Biologics, and Others), by Type of Poultry (Chickens, Ducks, and Others), by Distribution Channel (Veterinary Clinics, Veterinary Hospitals, and Retail Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Poultry Anticoccodial Drugs Market Size & Share Analysis - Growth, Trends And Forecast (2025 - 2030)

Poultry Anticoccodial Drugs Market Size

Poultry Anticoccodial Drugs Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 1.43 Billion
Market Size (2030) USD 1.74 Billion
CAGR (2025 - 2030) 3.95 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Poultry Anticoccodial Drugs Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Poultry Anticoccodial Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Poultry Anticoccodial Drugs Market Analysis

The Poultry Anticoccodial Drugs Market size is estimated at USD 1.43 billion in 2025, and is expected to reach USD 1.74 billion by 2030, at a CAGR of 3.95% during the forecast period (2025-2030).

A significant burden of coccidiosis in poultry animals across the globe is expected to boost the market. Coccidiosis is one of the most severe enteric problems in the poultry industry. The most catastrophic Eimeria tenella outbreaks occurred in the early stages of intensive chicken farming. Coccidiosis is a widespread disease in poultry farming, leading to significant economic losses. For instance, according to a research article published in Frontiers in March 2024, avian coccidiosis can cause substantial financial losses, with an estimated global cost to the poultry industry of approximately USD 12.00 billion annually.

The high prevalence of coccidiosis drives the demand for anticoccidial drugs to control and prevent outbreaks. According to a study article published in Veterinary Medicine and Science in July 2024, a meta-analysis revealed that eimeria tenella is the most prevalent species to cause infection in chickens. Moreover, the study also recommended that addressing eimeria impact is crucial not only for safeguarding poultry health but also for sustaining the economic viability of the poultry industry. Furthermore, a research study published in the Journal of BMC Veterinary Research in May 2024 showed that the prevalence of coccidiosis disease in broiler farms in the Guangdong province of China is 98.88% at the farm level and 87.06% at the flock level.

Additionally, according to data published by veterinaria digital, in September 2022, stated that the prevalence of coccidiosis in broilers to fluctuate between 5% and 70% depending on many factors, such as high temperature, humidity conditions in India.

Thus, the burden of coccidiosis among the poultry and high prevalence of coccidiosis demands the availability of the anticoccidial drugs. As a result, market growth is expected during the analysis period.

Poultry Anticoccodial Drugs Industry Overview

The poultry anticoccidial drugs market is moderately competitive in nature due to the presence of big companies operating globally. Each entity contributes to this comppetativeness through unique innovations, regional launches, partnerships with diverse organizations, and promotions across various leading platforms. Some of the key players operating in the market are Boehringer lngelheim International GmbH, Elanco, Merck & Co., Inc., Huve Pharma, and Zoetis among others.

Poultry Anticoccodial Drugs Market Leaders

  1. Boehringer lngelheim International GmbH

  2. Elanco

  3. Merck & Co., Inc.

  4. Zoetis

  5. Huve Pharma

  6. *Disclaimer: Major Players sorted in no particular order
Poultry Anticoccodial Drugs Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Poultry Anticoccodial Drugs Market News

  • January 2024: Boehringer Ingelheim has unveiled Vaxxilive Cocci 3, a poultry coccidiosis vaccine, which was formerly branded as Hatchpak Cocci III. The vaccine works to stimulate the bird’s natural immune response while minimizing tissue damage
  • March 2022: Amlan International launched two new natural alternatives to antibiotics for poultry and livestock, such as Phylox Feed and NeutraPath. Phylox Feed is a natural alternative to anticoccidial drugs and vaccines that can help producers increase profitability.

Poultry Anticoccodial Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Incidence of Coccidiosis in Poultry at a Global Level
    • 4.2.2 Advancements in Poultry Healthcare
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with the Treatment Options
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Drug Class
    • 5.1.1 Ionophore
    • 5.1.2 Antibiotic
    • 5.1.3 Sulphonamides
    • 5.1.4 Biologics (Anticoccidial Vaccines)
    • 5.1.5 Others
  • 5.2 By Type of Poultry
    • 5.2.1 Chickens
    • 5.2.1.1 Broiler Chickens
    • 5.2.1.2 Laying Chickens
    • 5.2.2 Ducks
    • 5.2.3 Others
  • 5.3 By Distribution Channel
    • 5.3.1 Veterinary Clinics
    • 5.3.2 Veterinary Hospitals
    • 5.3.3 Retail Pharmacies
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biochem Pharma
    • 6.1.2 Boehringer lngelheim International GmbH
    • 6.1.3 Ceva
    • 6.1.4 Elanco
    • 6.1.5 HIPRA
    • 6.1.6 Huvepharma
    • 6.1.7 lmpextraco NV
    • 6.1.8 Merck & Co., Inc. (MSD Animal Health)
    • 6.1.9 Phibro Animal Health Corporation
    • 6.1.10 Huve Pharma
    • 6.1.11 Virbac
    • 6.1.12 Zoetis
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Poultry Anticoccodial Drugs Industry Segmentation

As per the scope of the report, poultry anticoccidial drugs are medications used to prevent and treat coccidiosis, a common and economically significant parasitic disease in poultry caused by protozoan parasites of the genus Eimeria. These drugs are essential for maintaining the health and productivity of poultry flocks by controlling coccidiosis outbreaks.

The poultry anticoccidial drugs market is segmented by drug class, by type of poultry, and distribution channel. In terms of drug class, the market is segmented as ionophore, antibiotic, sulphonamides, biologics, and others. By type of poultry, the market is segmented as chickens, ducks, and others. By distribution channel, the market is segmented into veterinary clinics, veterinary hospitals, and retail pharmacies. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD) for the above segments.

By Drug Class Ionophore
Antibiotic
Sulphonamides
Biologics (Anticoccidial Vaccines)
Others
By Type of Poultry Chickens Broiler Chickens
Laying Chickens
Ducks
Others
By Distribution Channel Veterinary Clinics
Veterinary Hospitals
Retail Pharmacies
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Poultry Anticoccodial Drugs Market Research FAQs

How big is the Poultry Anticoccodial Drugs Market?

The Poultry Anticoccodial Drugs Market size is expected to reach USD 1.43 billion in 2025 and grow at a CAGR of 3.95% to reach USD 1.74 billion by 2030.

What is the current Poultry Anticoccodial Drugs Market size?

In 2025, the Poultry Anticoccodial Drugs Market size is expected to reach USD 1.43 billion.

Who are the key players in Poultry Anticoccodial Drugs Market?

Boehringer lngelheim International GmbH, Elanco, Merck & Co., Inc., Zoetis and Huve Pharma are the major companies operating in the Poultry Anticoccodial Drugs Market.

Which is the fastest growing region in Poultry Anticoccodial Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Poultry Anticoccodial Drugs Market?

In 2025, the North America accounts for the largest market share in Poultry Anticoccodial Drugs Market.

What years does this Poultry Anticoccodial Drugs Market cover, and what was the market size in 2024?

In 2024, the Poultry Anticoccodial Drugs Market size was estimated at USD 1.37 billion. The report covers the Poultry Anticoccodial Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Poultry Anticoccodial Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Poultry Anticoccodial Drugs Industry Report

Statistics for the 2025 Poultry Anticoccodial Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Poultry Anticoccodial Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.